[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100587475":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":29,"centralContacts":33,"locations":38,"responsibleParty":53,"collaborators":24,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":62,"eligibilityCriteria":63,"healthyVolunteers":58,"sex":64,"minAge":65,"maxAge":66,"enrollmentInfo":67,"targetDuration":24,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":77,"overallStatus":80,"whyStopped":24,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Ankara Etlik City Hospital","OTHER_GOV",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Group MAP 55-65 mmHg","OTHER","Group - MAP 55-65 mmHg: MAP will be maintained between 55-65 mmHg during anesthesia.",[13],"Other: MAP 55-65 mmHg",{"label":15,"type":10,"description":16,"interventionNames":17},"Group MAP 66-75 mmHg","Group - MAP 66-75 mmHg: MAP will be maintained between 66-75 mmHg during anesthesia.",[18],"Other: MAP 66-75 mmHg",[20,25],{"type":10,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"MAP 55-65 mmHg","MAP will be maintained between 55-65 mmHg during anesthesia.",[9],null,{"type":10,"name":26,"description":27,"armGroupLabels":28,"otherNames":24},"MAP 66-75 mmHg","MAP will be maintained between 66-75 mmHg during anesthesia.",[15],[30],{"name":31,"affiliation":5,"role":32},"damla usalan","PRINCIPAL_INVESTIGATOR",[34],{"name":31,"role":35,"phone":36,"phoneExt":24,"email":37},"CONTACT","+905059181063","dusalan78@gmail.com",[39],{"facility":5,"status":24,"city":40,"state":41,"zip":42,"country":43,"countryCode":24,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Ankara","Varlık Mahallesi Yenimahalle","06170","Turkey (Türkiye)",{"type":45,"coordinates":46},"Point",[47,48],32.85427,39.91987,{"lat":48,"lon":47},[51],{"name":31,"role":35,"phone":52,"phoneExt":24,"email":24},"+903127970000",{"type":32,"investigatorFullName":54,"investigatorTitle":55,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"Damla Usalan","Principal Investigator","100587475","the-effect-of-controlled-hypotension-100587475",false,"NCT06928870","The Effect of Controlled Hypotension","The Effect of Controlled Hypotension on Cerebral Oxygen Saturation in Spinal Surgery","NIRS","Inclusion Criteria:\n\n* Aged 18-65 years\n* ASA I-III risk group\n* BMI between 18-40\n* Baseline blood pressure below 140\u002F90 mmHg\n* Scheduled to undergo spinal surgery (2-4 level instrumentation)\n\nExclusion Criteria:\n\n* Below 18 or above 65 years old\n* Advanced comorbidities\n* ASA IV or higher\n* Baseline blood pressure above 140\u002F90 mmHg\n* History of bleeding diathesis\n* Use of anticoagulant medications\n* BMI below 18 or above 40\n* History of previous spinal surgery","ALL","18 Years","65 Years",{"count":68,"type":69},60,"ESTIMATED","INTERVENTIONAL",[72],"NA","Controlled hypotension is currently used in spinal surgery to reduce bleeding at the surgical site, improve the surgeon's visibility, and decrease intraoperative blood loss. Although controlled hypotension is considered a beneficial method from a surgical perspective, it is important to be cautious about its side effects. One such side effect is cerebral perfusion insufficiency, which can be managed by monitoring cerebral circulation through regional cerebral oxygen saturation (rSO2).\n\nThe aim of this study is to compare the effects of controlled hypotension at specific MAP ranges on cerebral oxygen saturation.",[75,76],"Cerebral Hypoperfusion","Hypotension",[78,62,79],"cerebral oxygen saturation","controlled hypotension","NOT_YET_RECRUITING","2025-04-14",{"date":83,"type":84},"2025-04-15","ACTUAL",{"date":86,"type":69},"2025-04-30",{"date":88,"type":69},"2025-06-30",{"name":5,"class":6},1]